649 related articles for article (PubMed ID: 35897036)
1. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
[TBL] [Abstract][Full Text] [Related]
2. A PD-L1-targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition-Mediated Synergistic Antitumor Metabolic and Immune Therapy.
Jin XK; Zhang SM; Liang JL; Zhang SK; Qin YT; Huang QX; Liu CJ; Zhang XZ
Adv Mater; 2024 Feb; 36(6):e2309094. PubMed ID: 38014890
[TBL] [Abstract][Full Text] [Related]
3. Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies.
Ma G; Li C; Zhang Z; Liang Y; Liang Z; Chen Y; Wang L; Li D; Zeng M; Shan W; Niu H
Front Oncol; 2021; 11():697894. PubMed ID: 34327138
[TBL] [Abstract][Full Text] [Related]
4. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.
Zhao L; Liu Y; Zhang S; Wei L; Cheng H; Wang J; Wang J
Cell Death Dis; 2022 Apr; 13(4):378. PubMed ID: 35444235
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
6. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
[TBL] [Abstract][Full Text] [Related]
7. The cancer metabolic reprogramming and immune response.
Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
[TBL] [Abstract][Full Text] [Related]
8. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
[TBL] [Abstract][Full Text] [Related]
9. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
10. Cell-programmed nutrient partitioning in the tumour microenvironment.
Reinfeld BI; Madden MZ; Wolf MM; Chytil A; Bader JE; Patterson AR; Sugiura A; Cohen AS; Ali A; Do BT; Muir A; Lewis CA; Hongo RA; Young KL; Brown RE; Todd VM; Huffstater T; Abraham A; O'Neil RT; Wilson MH; Xin F; Tantawy MN; Merryman WD; Johnson RW; Williams CS; Mason EF; Mason FM; Beckermann KE; Vander Heiden MG; Manning HC; Rathmell JC; Rathmell WK
Nature; 2021 May; 593(7858):282-288. PubMed ID: 33828302
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu.
Wang R; Hu Q; Wu Y; Guan N; Han X; Guan X
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188962. PubMed ID: 37541532
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic Nanoplatform Loading Type I Aggregation-Induced Emission Photosensitizer and Glutamine Blockade to Regulate Nutrient Partitioning for Enhancing Antitumor Immunotherapy.
Xie W; Chen B; Wen H; Xiao P; Wang L; Liu W; Wang D; Tang BZ
ACS Nano; 2022 Jul; 16(7):10742-10753. PubMed ID: 35830505
[TBL] [Abstract][Full Text] [Related]
13. Immunological Aspects of Cancer Cell Metabolism.
Ucche S; Hayakawa Y
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791327
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
15. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
[TBL] [Abstract][Full Text] [Related]
16. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
17. Metabolic interventions: A new insight into the cancer immunotherapy.
Yu T; Dong T; Eyvani H; Fang Y; Wang X; Zhang X; Lu X
Arch Biochem Biophys; 2021 Jan; 697():108659. PubMed ID: 33144083
[TBL] [Abstract][Full Text] [Related]
18. Does oncolytic viruses-mediated metabolic reprogramming benefit or harm the immune microenvironment?
Peng C; Xiao P; Li N
FASEB J; 2024 Feb; 38(3):e23450. PubMed ID: 38294796
[TBL] [Abstract][Full Text] [Related]
19. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints.
Xu Y; He L; Fu Q; Hu J
Front Oncol; 2021; 11():759015. PubMed ID: 34858835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
